Meeting
2016 ASCO Annual Meeting
Efficacy of front-line chemotherapy for recurrent/metastatic adenosarcoma of the uterus.
Authors
Michael Nathenson
University of Maryland Medical Center, Baltimore, MD
Michael Nathenson , Anthony Paul Conley , Ravin Ratan , Maria Alejandra Zarzour , Neeta Somaiah , Dejka M. Araujo , Shreyaskumar Patel , Robert S. Benjamin , Vinod Ravi
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Sarcoma
Track
Sarcoma
Sub Track
Soft Tissue Tumors
Citation
J Clin Oncol 34, 2016 (suppl; abstr 11058)
DOI
10.1200/JCO.2016.34.15_suppl.11058
Abstract #
11058
Poster Bd #
184
Abstract Disclosures
Similar Posters
Poster
2020 Gastrointestinal Cancers Symposium
The real-world practiсe of surgery in patients with metastatic gastric cancer (mGC).
First Author: Ekaterina Obarevich
Poster
2018 Gastrointestinal Cancers Symposium
Efficacy of nab-paclitaxel plus gemcitabine (AG) vs. FOLFIRINOX as first line chemotherapy for metastatic pancreatic cancer (mPC): Real world experiences.
First Author: Inhwang Hwang
Poster
2015 ASCO Annual Meeting
Phase 2 study of gemcitabine, docetaxel, and doxorubicin in patients with advanced, unresectable, and/or metastatic sarcoma who have failed prior therapies.
First Author: Andrew Eugene Hendifar
Poster
2014 ASCO Annual Meeting
Low-dose gemcitabine doxorubicin and docetaxel combination in patients with advanced/unresectable/metastatic sarcoma who failed prior chemotherapy: Updated analysis.
First Author: Vivek Narasimhan